Consistent safety and infectivity in sporozoite challenge model of Plasmodium vivax in malaria-naive human volunteers

American Journal of Tropical Medicine and Hygiene

Volumn 84, Issue 2 S, 2011, Pages 4-11

  Herrera, Sócrates ^a,e   Solarte, Yezid ^a   Jordań Villegas, Alejandro ^a   Echavarriá, Juan Fernando ^a   Rocha, Leonardo ^a   Palacios, Ricardo ^b   Ramiŕez, Oścar ^c   Veĺez, Juan D ^c   Epstein, Judith E ^d   Richie, Thomas L ^d   Arev́alo Herrera, Myriam ^a  

^a UNIVERSIDAD DEL VALLE   (Colombia)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FUNDACIÓN VALLE DEL LILI   (Colombia)

^d NAVAL MEDICAL RESEARCH CENTER   (United States)

^e Malaria Vaccine and Drug Development Center   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; MALARIA VACCINE; PRIMAQUINE; ANTIMALARIAL AGENT;

ADULT; ARTICLE; BLURRED VISION; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL LABORATORY; CONTROLLED STUDY; DIARRHEA; DIZZINESS; DRUG EFFICACY; DRUG SAFETY; EPIGASTRIC PAIN; FEMALE; FOLLOW UP; HUMAN; MALE; NAUSEA; PARASITEMIA; PLASMODIUM VIVAX MALARIA; RANDOMIZED CONTROLLED TRIAL; SPOROZOITE; TREATMENT RESPONSE; ANIMAL; BLOOD GROUP DUFFY SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE TRANSMISSION; FEVER; IMMUNOLOGY; MIDDLE AGED; PARASITOLOGY; PHYSIOLOGY; PLASMODIUM VIVAX; RANDOMIZATION;

ANOPHELES ALBIMANUS; PLASMODIUM VIVAX;

ADULT; ANIMALS; ANTIMALARIALS; CHLOROQUINE; DUFFY BLOOD-GROUP SYSTEM; FEMALE; FEVER; HUMANS; MALARIA, VIVAX; MALE; MIDDLE AGED; PARASITEMIA; PLASMODIUM VIVAX; PRIMAQUINE; RANDOM ALLOCATION; SPOROZOITES; YOUNG ADULT;

EID: 79952475565     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2011.09-0498     Document Type: Article

References (39)

1. Mendis K, Sina BJ, Marchesini P, Carter R, 2001. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 64: 97-106. (Pubitemid 32552576)
2. Herrera S, Bonelo A, Perlaza BL, Fernandez OL, Victoria L, Lenis AM, Soto L, Hurtado H, Acuna LM, Velez JD, Palacios R, Chen-Mok M, Corradin G, Arévalo-Herrera M, 2005. Safety and elicitation of humoral and cellular responses in Colombian malaria-naive volunteers by a Plasmodium vivax circumsporozoite proteinderived synthetic vaccine. Am J Trop Med Hyg 73: 3- 9.
3. Malkin EM, Durbin AP, Diemert DJ, Sattabongkot J, Wu Y, Miura K, Long CA, Lambert L, Miles AP, Wang J, Stowers A, Miller LH, Saul A, 2005. Phase 1 vaccine trial of Pv s25H: a transmission blocking vaccine for Plasmodium vivax malaria. Vaccine 23: 3131-3138.
4. Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP, 2008. Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pv s25 formulated with montanide ISA 51. PLoS ONE 3: e2636.
5. Bell BA, Wood JF, Bansal R, Ragab H, Cargo J 3rd, Washington MA, Wood CL, Ware LA, Ockenhouse CF, Yadava A, 2009. Process development for the production of an E.coli produced clinical grade recombinant malaria vaccine for Plasmodium vivax. Vaccine 27: 1448-1453.
6. Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, Losonsky G, Hollingdale M, Sztein M, Levine M, Nussenzweig RS, Clyde D, Edelman R, 1991. Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals. Am J Trop Med Hyg 45: 539-547.
7. Chulay JD, Schneider I, Cosgriff TM, Hoffman SL, Ballou WR, Quakyi IA, Carter R, Trosper JH, Hockmeyer WT, 1986. Malaria transmitted to humans by mosquitoes infected from cultured Plasmodium falciparum. Am J Trop Med Hyg 35: 66-68. (Pubitemid 16140838)
8. Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, Hollingdale MR, Ballou WR, Gordon DM, 1993. Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites. Am J Trop Med Hyg 49: 166-173. (Pubitemid 23267573)
9. Trager W, Jensen JB, 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
10. Ponnudurai T, Verhave JP, Meuwissen JH, 1982. Mosquito transmission of cultured Plasmodium falciparum. Trans R Soc Trop Med Hyg 76: 278-279.
11. Epstein JE, Rao S, Williams F, Freilich D, Luke T, Sedegah M, de la Vega P, Sacci J, Richie TL, Hoffman SL, 2007. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum -infected mosquitoes: an update. J Infect Dis 196: 145-154. (Pubitemid 46982749)
12. Herrera S, Fernandez O, Manzano MR, Murrain B, Vergara J, Blanco P, Palacios R, Velez JD, Epstein JE, Chen-Mok M, Reed ZH, Arévalo-Herrera M, 2009. Successful sporozoite challenge model in human volunteers with Plasmodium vivax strain derived from human donors. Am J Trop Med Hyg 81: 740-746.
13. Hurtado S, Salas ML, Romero JF, Zapata JC, Ortiz H, Arévalo- Herrera M, Herrera S, 1997. Regular production of infective sporozoites of Plasmodium falciparum and P. vivax in laboratory-bred Anopheles albimanus. Ann Trop Med Parasitol 91: 49-60. (Pubitemid 27081179)
14. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, 1993. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: 283-292.
15. Graves PM, 1980. Studies on the use of a membrane feeding technique for infecting Anopheles gambiae with Plasmodium falciparum. Trans R Soc Trop Med Hyg 74: 738-742.
16. Peters W, Ramkaran AE, 1980. The chemotherapy of rodent malaria, XXXII. The influence of p-aminobenzoic acid on the transmission of Plasmodium yoelii and P. berghei by Anopheles stephensi. Ann Trop Med Parasitol 74: 275-282. (Pubitemid 10000359)
17. Rickman LS, Jones TR, Long GW, Paparello S, Schneider I, Paul CF, Beaudoin RL, Hoffman SL, 1990. Plasmodium falciparum-infected Anopheles stephensi inconsistently transmit malaria to humans. Am J Trop Med Hyg 43: 441-445.
18. Solarte Y, Manzano MM, Rocha L, Hurtado H, James MA, Arevalo-Herrera M, Herrera S, 2011. Plasmodium vivax sporozoites production in Anopheles mosquitoes for vaccine clinical trials. Am J Trop Med Hyg 84 (Suppl 2): 28-34.
19. Gamage-Mendis AC, Rajakaruna J, Weerasinghe S, Mendis C, Carter R, Mendis KN, 1993. Infectivity of Plasmodium vivax and P. falciparum to Anopheles tesellatus: relationship between oocyst and sporozoite development. Trans R Soc Trop Med Hyg 87: 3-6.
20. Church LW, Le TP, Bryan JP, Gordon DM, Edelman R, Fries L, Davis JR, Herrington DA, Clyde DF, Shmuklarsky MJ, Schneider I, McGovern TW, Chulay JD, Ballou WR, Hoffman SL, 1997. Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis 175: 915-920. (Pubitemid 27142967)
21. Powell RD, McNamara JV, 1970. Infection with chloroquine-resistant Plasmodium falciparum in man: prepatent periods, incubation periods, and relationships between parasitemia and the onset of fever in nonimmune persons. Ann N Y Acad Sci 174: 1027-1041.
22. Verhage DF, Telgt DS, Bousema JT, Hermsen CC, van Gemert GJ, van der Meer JW, Sauerwein RW, 2005. Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med 63: 52-58. (Pubitemid 40347734)
23. Vaughan JA, Noden BH, Beier JC, 1994. Sporogonic development of cultured Plasmodium falciparum in six species of laboratory-reared Anopheles mosquitoes. Am J Trop Med Hyg 51: 233- 243.
24. Cavasini CE, Mattos LC, Couto AA, Bonini-Domingos CR, Herrera S, Neiras WC, Alves RT, Rossit AR, Castilho L, Machado RL, 2007. Plasmodium vivax infection among Duffy antigen-negative individuals from the Brazilian Amazon region: an exception? Trans R Soc Trop Med Hyg 101: 1042-1044. (Pubitemid 47336851)
25. Ménard D, Barnadas C, Bouchier C, Henry-Halldin C, Gray LR, Ratsimbasoa A, Thonier V, Carod JF, Domarle O, Colin Y, Bertrand O, Picot J, King CL, Grimberg BT, Mercereau-Puijalon O, Zimmerman PA, 2010. Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A 30: 5967-5971.
26. Kelly-Hope LA, McKenzie FE, 2009. The multiplicity of malaria transmission: a review of entomological inoculation rate measurements and methods across sub-Saharan Africa. Malar J 8: 19.
27. Sattabongkot J, Maneechai N, Phunkitchar V, Eikarat N, Khuntirat B, Sirichaisinthop J, Burge R, Coleman RE, 2003. Comparison of artificial membrane feeding with direct skin feeding to estimate the infectiousness of Plasmodium vivax gametocyte carriers to mosquitoes. Am J Trop Med Hyg 69: 529-535. (Pubitemid 38248255)
28. Bonnet S, Gouagna C, Safeukui I, Meunier JY, Boudin C, 2000. Comparison of artificial membrane feeding with direct skin feeding to estimate infectiousness of Plasmodium falciparum gametocyte carriers to mosquitoes. Trans R Soc Trop Med Hyg 94: 103-106.
29. van der Kolk M, De Vlas SJ, Saul A, van de Vegte-Bolmer M, Eling WM, Sauerwein RW, 2005. Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitol 130: 13-22.
30. Beier JC, Beier MS, Vaughan JA, Pumpuni CB, Davis JR, Noden BH, 1992. Sporozoite transmission by Anopheles freeborni and Anopheles gambiae experimentally infected with Plasmodium falciparum. J Am Mosq Control Assoc 8: 404-408.
31. Beier JC, Onyango FK, Ramadhan M, Koros JK, Asiago CM, Wirtz RA, Koech DK, Roberts CR, 1991. Quantitation of malaria sporozoites in the salivary glands of wild Afrotropical Anopheles. Med Vet Entomol 5: 63-70.
32. Beier JC, Onyango FK, Koros JK, Ramadhan M, Ogwang R, Wirtz RA, Koech DK, Roberts CR, 1991. Quantitation of malaria sporozoites transmitted in vitro during salivation by wild Afrotropical Anopheles. Med Vet Entomol 5: 71-79.
33. Russell B, Suwanarusk R, Lek-Uthai U, 2006. Plasmodium vivax genetic diversity: microsatellite length matters. Trends Parasitol 22: 399-401. (Pubitemid 44176408)
34. Imwong M, Nair S, Pukrittayakamee S, Sudimack D, Williams JT, Mayxay M, Newton PN, Kim JR, Nandy A, Osorio L, Carlton JM, White NJ, Day NP, Anderson TJ, 2007. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. Int J Parasitol 37: 1013-1022. (Pubitemid 46887595)
35. Karunaweera ND, Ferreira MU, Munasinghe A, Barnwell JW, Collins WE, King CL, Kawamoto F, Hartl DL, Wirth DF, 2008. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene 410: 105-112.
36. Bozdech Z, Mok S, Hu G, Imwong M, Jaidee A, Russell B, Ginsburg H, Nosten F, Day NP, White NJ, Carlton JM, Preiser PR, 2008. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA 105: 16290-16295.
37. Kim JR, Imwong M, Nandy A, Chotivanich K, Nontprasert A, Tonomsing N, Maji A, Addy M, Day NP, White NJ, Pukrittayakamee S, 2006. Genetic diversity of Plasmodium vivax in Kolkata, India. Malar J 5: 71.
38. Ferreira MU, Karunaweera ND, da Silva-Nunes M, da Silva NS, Wirth DF, Hartl DL, 2007. Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia. J Infect Dis 195: 1218-1226. (Pubitemid 46543456)
39. Kasehagen LJ, Mueller I, Kiniboro B, Bockarie MJ, Reeder JC, Kazura JW, Kastens W, McNamara DT, King CH, Whalen CC, Zimmerman PA, 2007. Reduced Plasmodium vivax erythrocyte infection in PNG Duffy-negative heterozygotes. PLoS ONE 2: e336.